IBC’s Inaugural Startup Forum Attracts Big-Name Media Companies Looking for New Business Opportunities
IBC’s inaugural Startup Forum looks set to create some exciting new partnerships, with big-name organisations attending to find start-up or growth companies from countries around the world with the next big idea. The Startup Forum, held on Sunday 17 September, is run in association with Media Honeypot, organisers of the eponymous international conference that helps startups and growing companies to identify new business opportunities, growth strategies and potential partnerships.
Over 75 startups and growing businesses have been selected from 22 countries, across areas including VR/AR, sports, micro-payments, marketing, streaming video and publishing. Each company has been pre-qualified, ensuring they have at least a minimum viable product, revenue potential of 20 million Euros, and ambitions to expand in different markets with a developed growth strategy.
Some of the startups include:
- Oovvuu (Australia) - uses artificial intelligence to match broadcasters' videos and publishers' articles on a global scale, changing the way video is watched, distributed and monetised
- Tiledmedia (Netherlands) - a VR streaming company that enables high quality VR360 streaming at realistic bitrates
- LiveWeatherViews (Australia) - developing a timelapse camera system to help TV networks capture great weather vision with full automation over IP
- Choicely (Finland) - developing a fan engagement platform to help publishers and advertisers to engage their audiences better using their highly developed interactive formats
- SatoshiPay (Germany) - processes nanopayment transactions usually in the form of bitcoins. The company is developing a two-way payment platform that will allow content providers to charge consumers a small fee to read, watch or listen to content
- Giraffic (US/Israel/Hong Kong) - a market leader in client-side multimedia software acceleration, helping device manufacturers and OTT content providers overcome internet congestion challenges in order to provide their customers with an enjoyable, engaging user experience.
Heikki Rotko, Founder and Chairman, Media Honeypot, said, “I am astonished by the level of media innovation that happens outside of media companies. The selected startups represent such a huge amount of knowledge and innovation that every media house should be interested in.”
Media companies attending with a view to partner with these organisations include Sky, MTV Oy, Cisco Systems, VRT, ProSiebenSat.1 Commerce GmbH, The Venture Reality Fund and HTC.
As well as networking opportunities, the seminar programme features key speakers including Joost Brakel, Director, Digital Operations, Sanoma NL; Jakob Wais, Head of New Platforms & Video, Content Strategy, BILD; Sara Lisa Vogl, Co-Founder, VR Base; and Teresa Potocka, CEO and Founder of The Potocki Communications Company, who will share invaluable insights into the latest developments in media technology and how they can be harnessed into successful business opportunities.
IBC is also delighted to welcome HRH Constantijn van Oranje-Nassau who leads StartupDelta, the accelerator for the startup ecosystem in the Netherlands, and advises companies and the European Commission on their digital innovation strategies. He is a regular speaker at national and international tech conferences and holds a number of positions in both the public and private sector. His Royal Highness will take part in the Startup Corporate Collaboration track where the Rules of Engagement will be discussed.
In addition, five startups will be selected to take part in a Pitching Competition, pitching their business ideas to industry experts and receiving direct feedback from an expert panel. The winning company will also receive a cash prize.
## ENDS ##
IBC is the world’s leading media, entertainment and technology show. It attracts 55,000+ attendees from more than 170 countries and combines a highly respected and peer-reviewed conference with an exhibition that showcases more than 1,700 leading suppliers of state of the art electronic media and entertainment technology.
Conference: 14 – 18 September 2017
Exhibition: 15 – 19 September 2017
For more information about IBC2017 visit: https://show.ibc.org/
Louise Wells, Bubble Communications
T: +44 7718 985 252
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 11:00 | Pressemelding
Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines
Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 08:10 | Pressemelding
Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest
Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 15:13 | Pressemelding
Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,
Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 14:00 | Pressemelding
Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With
Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 13:41 | Pressemelding
Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel
Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 12:00 | Pressemelding
Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i